Substituted heterocycles as bromodomain inhibitors
申请人:Zenith Epigenetics Ltd.
公开号:US10292968B2
公开(公告)日:2019-05-21
The present application relates to substituted heterocycles compound of Formula I and pharmaceutical compositions thereof useful for the inhibition of BET protein function by binding to bromodomains (Formula I).
本申请涉及式 I 的取代杂环化合物及其药物组合物,该化合物通过与溴化结构域(式 I)结合,可用于抑制 BET 蛋白的功能。